UNSPSC 51282319: Erythromycin f

This classification denotes a macrolide antibiotic with the molecular formula C37H67NO14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NM325T380N, chemically known as erythromycin, 16-hydroxy-, but more generally known as erythromycin f, which bears US NIH Compound Identifier 6426644. European Medicines Agency schedules erythromycin f or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06605MIG. Most nations, for tariff purposes, schedule erythromycin f under HS 29415000.

SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)CO)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O.

UNSPSC 51282319 Erythromycin f is a Commodity code that nominally names a specific antibiotic product, but the recent state and local opportunities tagged under it show pharmaceutical procurement across a broader spectrum. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets under an Invitation for Bid process, while Seminole County, Florida sought Naloxone and Safe Drug Deactivation Systems through a competitive bidding process in mid-2026. The mismatch between the code's nominal scope and the actual products being bought suggests that state and local procurement offices are using this Commodity code as a broader pharmaceutical category rather than a strict drug-specific designation. Issuing bodies using the code span state health departments and county public health entities pursuing emergency preparedness and community health inventory through cooperative purchasing vehicles and direct IFB processes.

Recent activity concentrates in Illinois and Florida, with the Illinois Department of Public Health appearing as a repeat cooperative-purchasing participant and Seminole County pursuing public health supplies. The Illinois award reflected a 12-month initial term with renewal options through year three, while the Seminole County solicitation (posted June 30, 2026, with response due July 26, 2026) structured quarterly deliveries and included two-year initial terms with one-year renewal options. Neither procurement applied explicit set-aside designations for disadvantaged enterprises. The code shows modest recent activity limited to health-sector buyers, and firms pursuing this Commodity should note the disconnect between erythromycin-specific naming and the actual pharmaceutical and medical-device mix state and local procurement offices are sourcing under it.